1. Home
  2. SER vs AIXI Comparison

SER vs AIXI Comparison

Compare SER & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • AIXI
  • Stock Information
  • Founded
  • SER 2017
  • AIXI 2001
  • Country
  • SER United States
  • AIXI China
  • Employees
  • SER N/A
  • AIXI N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • AIXI Computer Software: Prepackaged Software
  • Sector
  • SER Health Care
  • AIXI Technology
  • Exchange
  • SER Nasdaq
  • AIXI Nasdaq
  • Market Cap
  • SER 45.2M
  • AIXI 54.2M
  • IPO Year
  • SER 2018
  • AIXI 2023
  • Fundamental
  • Price
  • SER $4.81
  • AIXI $5.85
  • Analyst Decision
  • SER
  • AIXI
  • Analyst Count
  • SER 0
  • AIXI 0
  • Target Price
  • SER N/A
  • AIXI N/A
  • AVG Volume (30 Days)
  • SER 31.9K
  • AIXI 112.2K
  • Earning Date
  • SER 11-12-2024
  • AIXI 10-28-2024
  • Dividend Yield
  • SER N/A
  • AIXI N/A
  • EPS Growth
  • SER N/A
  • AIXI N/A
  • EPS
  • SER N/A
  • AIXI N/A
  • Revenue
  • SER $3,157,500.00
  • AIXI $65,643,604.00
  • Revenue This Year
  • SER N/A
  • AIXI $22.85
  • Revenue Next Year
  • SER N/A
  • AIXI $22.70
  • P/E Ratio
  • SER N/A
  • AIXI N/A
  • Revenue Growth
  • SER 2454.55
  • AIXI 6.22
  • 52 Week Low
  • SER $3.81
  • AIXI $2.06
  • 52 Week High
  • SER $19.93
  • AIXI $22.05
  • Technical
  • Relative Strength Index (RSI)
  • SER 46.26
  • AIXI 53.52
  • Support Level
  • SER $4.70
  • AIXI $5.03
  • Resistance Level
  • SER $5.40
  • AIXI $5.71
  • Average True Range (ATR)
  • SER 0.49
  • AIXI 0.50
  • MACD
  • SER -0.01
  • AIXI -0.01
  • Stochastic Oscillator
  • SER 11.93
  • AIXI 61.81

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

Share on Social Networks: